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General Considerations: 
Hexamethylborazine,[1] 1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole,[2] 6-chloro-9-
tosyl-9H-purine,[3] 2-fluoroquinoline,[4] benzylpotassium,[5] dimsyl potassium,[6] dimsyl sodium,[7] 
2-nitro-5-phenylpyridine,[8] Pd(TMEDA)(Tol)I,[9] diphenoxy-chloro-triazine,[10] and K(18-crown-
6)(B3N3Me6CF3)(THF),
[11] K(BOCH2CH2N)3CF3,
[11]
 and N-tosylbenzaldimine
[12] were prepared 
according to literature procedures. DMSO, THF,  and DMF were purified using a Glass Contour 
solvent purification system through percolation through a Cu catalyst, molecular sieves, and 
alumina and finally stored over activated molecular sieves for a minimum of 48 hours. All other 
reagents were used from commercial sources without further purification. Unless otherwise noted, 
all manipulations were performed under an inert nitrogen atmosphere.  
NMR spectra were recorded on a Varian Vnmrs 700, Varian Vnmrs 500, or Varian MR400 
spectrometer. 1H, 13C, 19F, 11B, and 31P shifts are reported in parts per million (ppm) relative to 
TMS, with the residual solvent peak used as an internal reference. 31P, 11B, 77Se, 127Te, 29Si, and 
19F NMR spectra are referenced to fluorobenzene or, in specra lacking internal standard, on a 
unified scale, where the single primary reference is the frequency of the residual solvent peak in 
the 1H NMR spectrum. Peaks not listed in the peak assignment correspond to residual solvent.[13] 
Multiplicities are reported as follows: singlet (s), doublet (d), triplet (t), quartet (q), pentet (p), 
septet (sp), and multiplet (m). Mass spectra were obtained on an electrospray Agilent Q-TOF mass 
spectrometer or a Micromass AutoSpec Ultima Magnetic Sector Mass Spectrometer electron 
ionization mass spectrometer. NMR spectra were processed using MestReNova version 10.0.2. 
For the purpose of labeling atoms for spectral assignments, hydrogen atoms are labeled with greek 
letters while carbon atoms are labeled with numbers. In spectra of in-situ reactions, HCF3 and 
fluorobenzene (internal standard) appear at -78.52 and -113.15 ppm, respectively 
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Preparation of CF3- Reagent Stock Solutions 
K(18-crown-6)(B3N3Me6)CF3(THF) in THF:  
Hexamethylborazine (2.70 mmol, 0.443 g) and 18-crown-6 (2.70 mmol, 0.712 g) were dissolved 
in 11 mL THF in a 20 mL single-neck conical flask equipped with a large Teflon-coated magnetic 
stirbar. The vessel was then cooled to 0 °C for one hour with gentle stirring. Benzylpotassium 
(2.70 mmol, 0.350 g) was quickly added to this cold solution, and the initial deep red color of 
dissolved benzylpotassium quickly changed to light purple. The flask was then sealed with a belt-
clamped septum. HCF3 was added to the sealed vessel with a 60 mL syringe (3.3 mmol, 75 mL) 
and continuously stirred for 10 minutes. 19F NMR showed >99% yield of K(B3N3Me6CF3).  
K(B3N3Me6)CF3 in DMSO:  
Hexamethylborazine (2.70 mmol, 0.443 g) was suspended in 13 mL DMSO in a 20 mL single-
neck conical flask equipped with a large Teflon-coated magnetic stirbar, which was then sealed 
with a belt-clamped septum. Dimsyl potassium (1.80 M, 2.70 mmol, 1.50 mL) was then rapidly 
added via syringe, and the mixture was stirred for 30 minutes at 2000 rpm, which afforded a 
homogeneous solution. HCF3 was added to the sealed vessel with a 60 mL syringe (12.0 mmol, 
297 mL) and continuously stirred for 10 minutes. 19F NMR showed >99% yield of 
K(BOCH2CH2N)3CF3. The t1/2 of this solution (
19F NMR, 25 °C): 17 days 
K(BOCH2CH2N)3CF3 in DMSO:  
Trisethyleneoxyborazine (10.5 mmol, 2.17 g) was suspended in 43 mL DMSO in a 100 mL single-
neck round bottom flask equipped with a large Teflon-coated magnetic stirbar, which was then 
sealed with a belt-clamped septum. Dimsyl potassium (1.93 M, 10.0 mmol, 5.18 mL) was then 
rapidly added via syringe, and the mixture vigorously stirred for 30 minutes. HCF3 was added to 
the sealed vessel with a 60 mL syringe (12.0 mmol, 297 mL) and continuously stirred for 10 
minutes. 19F NMR showed 99% yield of K(BOCH2CH2N)3CF3 (based on KDMSO). The t1/2 of 
this solution (19F NMR, 25 °C): >5 months 
Preparation of 2b: 
 
Hexamethylborazine (3.15 mmol, 0.518 g), 18-crown-6 (6.30 mmol, 1.668 g) and cesium fluoride 
(3.00 mmol, 0.455 g) were combined in 10 mL THF. The mixture was stirred at 0 C for 50 
minutes. SiMe3CF3 (3.6 mmol, 0.53 mL), cooled to 0 °C, was slowly added to the mixture and the 
reaction stirred for 1.5 hours. Volatiles were removed under vacuum, and the resulting solid 
dissolved in 10 mL of THF and filtered. The filtrate was layered with 115 mL of Et2O, and allowed 
to stand for 3 days at -30 C to afford large crystals. Solvent was decanted from the crystals, which 
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were then washed with pentane (5x 15 mL). The residual solvent was allowed to evaporate at 
ambient pressure for 90 minutes to afford crystalline 2b (1.215g, 45%). A single crystal for 
structural analysis was prepared by layering Et2O on a concentrated THF solution of 2b at -30 °C. 
1H-NMR (DMSO-d6): 3.49 (ω, 48H, s), 2.47 (α, 3H, s), 2.42 (ε, 6H, s), -0.05 (β, 6H, s), -0.38 (γ, 
3H, s).  11B-NMR: 32.94 (2B), -5.77 (1B). 19F-NMR: -64.50 (3F (dd,  J11B-19F: 56, 22)). HRMS 
(ES+): 191.0195 (M+: 191.0194). Anal. Calcd for C31H66B3CsF3N3O12: C, 41.59; H, 7.43; N, 4.69. 
Found: C, 41.09; H, 6.95; N, 4.46. Samples were aged for 30 days at either 25 °C, during which 
time greater than 80% of the sample decomposed, or at or -30 °C, during which no decomposition 
was observed. The samples were subjected to elemental analysis (Anal. Calcd for 
C31H66B3CsF3N3O12: C, 41.59; H, 7.43; N, 4.69. Found (30 days at 25 °C): C, 41.67; H, 7.62; N, 
4.45), found (30 days at -30 °C): C, 41.42; H, 7.24; N, 4.66). Elemental analysis of the decomposed 
sample still closely matched the expected values for pure 2b, indicating that HCF3 gas is not a 
decomposition product.  
Fig. S1. 1H NMR Spectrum: 
 
 
 
 
Fig. S2. 13C NMR Spectrum: 
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Fig. S3. 19F NMR Spectrum: 
 
Fig. S4. X-Ray Crystal Structure: 
 
Selected bond distances: B1-C1: 1.630 Å, B1-C2: 1.644 Å, B1-N1: 1.553 Å, B1-N2: 1.546 Å, N1-
B2: 1.401 Å, N2-B3: 1.389 Å, N3-B2: 1.436 Å, N3-B3: 1.446 Å, C1-F1: 1.367 Å, C1-F2: 1.382 
Å, C1-F3: 1.393 Å 
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Stability of 2b at 25 C in Solid State 
 
2b decomposes at a rate of 3.4% per day (R2 = 0.998). Samples of pure solid (10-15 mg) were 
weighed into sealed vials and allowed to stand at 25°C for a desired amount of time. Mass 
percentage was determined by comparing the original mass of the sample to the number of moles 
of 2b determined by dissolving the sample and integrating its resonance in the 19F NMR spectrum 
against 10.0 µL added fluorobenzene standard.  
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Stability of 2b at 25 C in Solution 
 
A 0.2 M sample of 2b was prepared in an NMR tube and periodically monitored by 19F NMR 
spectroscopy at room temperature. Rate of decomposition: 0.00201 M/d R2 = 0.998 
Reactions with Inorganic Electrophiles 
General Protocol:  
To 0.100 mmol of substrate dissolved in 0.50 mL DMSO or THF was added 0.100 mmol K(18-
crown-6)(B3N3Me6)CF3 as a solution in matching solvent. Characterization of B(OMe)3CF3
- is 
provided for in our previous manuscript.[11]  
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Fig. S5. Trifluoromethylation of Inorganic Compounds 
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Pd(TMEDA)(Tol)CF3 
Experimental: Pd(TMEDA)(Tol)I (Tol=C6H4CH3) (22.0 mg, 0.0500 mmol) was placed in an NMR 
tube and dissolved in 1.5 mL THF. K(18-crown-6)(B3N3Me6CF3)(THF) (0.250 mL 0.20 M stock 
in THF, 0.0500 mmol) was then added and the NMR tube and vigorously shaken. 19F NMR spectra 
were recorded 10 minutes after CF3
- addition and the product peak integrated against 0.030 mmol 
fluorobenzene internal standard. The product conformed to literature spectra of Pd(TMEDA)(Ph). 
19F NMR (literature (in CDCl3): -21.14):
[9] -20.18 (3F, s). Yield: 98%. 
Fig. S6. In-Situ 19F NMR Spectrum: 
 
CuCF3 
Experimental: CuI (19.0 mg, 0.100 mmol) was placed in an NMR tube and dissolved in 0.50 mL 
DMSO. K(B3N3Me6CF3) (0.50 mL 0.20 M stock in DMSO, 0.100 mmol) was then added and the 
NMR tube vigorously shaken. 19F NMR spectra were recorded 10 minutes after CF3
- addition and 
the product peak integrated against 0.030 mmol fluorobenzene internal standard. The product 
conformed to literature spectra of CuCF3, in which a Schlenk equilibrium is observed. 
19F NMR 
(literature (in DMF): -28.8):[14] -29.24 (63%, s), -26.43 (19%, s). Yield: 83%. 
Fig. S7. In-Situ 19F NMR Spectrum: 
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Trifluoromethylbiphenyl 
Experimental: Biphenyl iodide (28.0 mg, 0.100 mmol) was added to the solution of CuCF3 
prepared and the NMR tube vigorously shaken. The mixture was heated to 80 °C for 12h. 19F NMR 
spectra were recorded and the product peak integrated against 0.030 mmol fluorobenzene internal 
standard. The product conformed to literature spectra of trifluoromethylbiphenyl. 19F NMR 
(literature (CDCl3): -62.4):
[15] -61.07 (3F, s).Yield: 66%. HRMS (EI+): 222.0659  (M+: 222.0656) 
Fig. S8. In-Situ 19F NMR Spectrum: 
 
AgCF3 
Experimental: AgNO3 (16.9 mg, 0.100 mmol) was placed in an NMR tube and dissolved in 0.50 
mL DMSO. K(B3N3Me6CF3) (0.50 mL 0.20 M stock in DMSO, 0.10 mmol) was then added and 
the NMR tube vigorously shaken. 19F NMR spectra were recorded 10 minutes after CF3
- addition 
and the product peak was integrated against 0.030 mmol fluorobenzene internal standard. The 
product conformed to literature spectra of AgCF3. In literature reports of AgCF3 compounds, the 
NMR shift varies between -20 and -30 and the coupling constant varies between 70 and 150 Hz 
depending on solvent and ancillary ligands.[16] 19F NMR (literature in DMF): -23-26,  J109Ag-19F = 
100-125):[17] -23.50 (3F, (d, J109Ag-19F = 91.7). Yield: 44%.  
Fig. S9. In-Situ 19F NMR Spectrum: 
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Au(iPr)CF3 
Experimental: Au(iPr)Cl (iPr=1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) (31 mg, 0.050 
mmol) was placed in an NMR tube and dissolved in 0.25 mL THF. K(18-crown-
6)(B3N3Me6CF3)(THF) (0.250 mL 0.20 M stock in THF, 0.0500 mmol) was then added and the 
NMR tube and vigorously shaken. 19F NMR spectra were recorded 10 minutes after CF3
- addition 
and the product peak integrated against 0.030 mmol fluorobenzene internal standard. The product 
conformed to literature spectra of Au(iPr)CF3. 
19F NMR (literature (in CD2Cl2): -28.4):
[18] -27.77 
(3F, s). Yield: 15%. 
Fig. S10. In-Situ 19F NMR Spectrum: 
 
Zn(TMEDA)(CF3)2 
Experimental: ZnCl2 (6.8 mg, 0.050 mmol) was placed in an NMR tube and dissolved in 0.5 mL 
THF. Tetramethylethylenediamine (TMEDA, 7.5 µL, 0.050 mmol) was then added and the 
homogeneous solution was allowed to stand for 10 minutes. K(18-crown-6)(B3N3Me6CF3)(THF) 
(0.50 mL 0.20 M stock in THF, 0.10 mmol) was then added and the NMR tube vigorously shaken. 
19F NMR spectra were recorded 10 minutes after CF3
- addition and the product peak integrated 
against 0.030 mmol fluorobenzene internal standard. The product conformed to literature spectra 
of Zn(TMEDA)(CF3)2. 
19F NMR (literature (in CDCl3): -40.5):
[19] -40.0 (6F, s). Yield: 74%. 
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Fig. S11. In-Situ 19F NMR Spectrum: 
 
SiMe3CF3 
Experimental: Trimethylsilyl chloride (10.8 mg, 0.100 mmol) was placed in an NMR tube and 
dissolved in 0.50 mL THF. K(18-crown-6)(B3N3Me6CF3)(THF) (0.50 mL 0.20 M stock in THF, 
0.10 mmol) was then added and the NMR tube vigorously shaken. 19F NMR spectra were recorded 
10 minutes after CF3
- addition and the product peak integrated against 0.30 mmol fluorobenzene 
internal standard. The product conformed to literature spectra of SiMe3CF3. 
19F NMR (literature 
(CDCl3): -66.81):
[11] -66.52 (3F, s). Yield: 99%. 
Fig. S12. In-Situ 19F NMR Spectrum: 
 
SnMe3CF3 
Experimental: Trimethyltin chloride (19.9 mg, 0.100 mmol) was placed in an NMR tube and 
dissolved in 0.50 mL THF. K(18-crown-6)(B3N3Me6CF3)(THF) (0.50 mL 0.20 M stock in THF, 
0.10 mmol) was then added and the NMR tube vigorously shaken. 19F NMR spectra were recorded 
10 minutes after CF3
- addition and the product peak integrated against 0.30 mmol fluorobenzene 
internal standard. The product conformed to literature spectra of SnMe3CF3. 
19F NMR (literature 
(neat liquid): -49.1, J119Sn-19F: 133):
[20] –50.33 (3F, s, (119Sn satellites: J119Sn-19F: 136). Yield: 73%. 
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Fig. S13. In-Situ 19F NMR Spectrum: 
 
PbMe3CF3 
Experimental: Trimethyllead bromide (33.0 mg, 0.100 mmol) was placed in an NMR tube and 
dissolved in 0.50 mL THF. K(18-crown-6)(B3N3Me6CF3)(THF) (0.50 mL 0.20 M stock in THF, 
0.10 mmol) was then added and the NMR tube vigorously shaken. 19F NMR spectra were recorded 
10 minutes after CF3
- addition and the product peak integrated against 0.30 mmol fluorobenzene 
internal standard. The product conformed to literature spectra of PbMe3CF3. 
19F NMR (literature 
(neat liquid): -43.9):[21]–43.8 (3F, s). Yield: 99%. 
Fig. S14. In-Situ 19F NMR Spectrum: 
 
KB(OMe)3CF3 
Experimental: Trimethyl borate (11.2 µL, 0.100 mmol) was placed in an NMR tube and dissolved 
in 0.50 mL DMSO. K(B3N3Me6CF3) (0.50 mL 0.20 M stock in DMSO, 0.10 mmol) was then 
added and the NMR tube was vigorously shaken. 19F NMR spectra were recorded 10 minutes after 
CF3
- addition and the product peak integrated against 0.3 mmol fluorobenzene internal standard. 
The product was confirmed by comparison with an authentic sample prepared according to 
literature methods[22] dissolved in DMSO-d6 (
19F-NMR: -65.41 (3F, dd,  J11B-19F: 49, 24)): -65.47 
(3F, dd,  J11B-19F: 49, 24). Yield: 80%. 
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Fig. S15. In-Situ 19F NMR Spectrum: 
 
 
PPh2CF3 
Experimental: Diphenylphosphine chloride (22.0 mg, 0.100 mmol) was placed in an NMR tube 
and dissolved in 0.50 mL THF. K(18-crown-6)(B3N3Me6CF3)(THF) (0.50 mL 0.20 M stock in 
THF, 0.10 mmol) was then added and the NMR tube vigorously shaken. After five minutes, 
colorless crystals had formed and the solution became yellow. 19F NMR spectra were recorded 10 
minutes after CF3
- addition and the product peak integrated against 0.11 mmol fluorobenzene 
internal standard. The product conformed to literature spectra of PPh2CF3. 
19F NMR (literature (in 
CDCl3): -55.3, J31P-19F: 73):
[23] -55.13 (3F, (d, J31P-19F: 73.2). Yield: 99%. 
Fig. S16. In-Situ 19F NMR Spectrum: 
 
Bi(CF3)2Cl 
Experimental: Bismuth trichloride (10.5 mg, 0.033 mmol) was placed in an NMR tube and 
combined with 0.50 mL THF. K(18-crown-6)(B3N3Me6CF3)(THF) (0.50 mL 0.20 M stock in THF, 
0.10 mmol) was then added and the NMR tube vigorously shaken. After five minutes, colorless 
crystals had formed along with a black precipitate. 19F NMR spectra were recorded 10 minutes 
after CF3
- addition and the product peak integrated against 0.03 mmol fluorobenzene internal 
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standard. The product conformed to literature spectra of Bi(CF3)2Cl. 
19F NMR (literature (in 
MeCN): -37.8):[24] -37.26. Yield: 42%. 
Fig. S17. In-Situ 19F NMR Spectrum: 
 
Reactions with Organic and Inorganic Chalcogens 
PhSCF3 
Experimental: Diphenyldisulfide (21.8 mg, 0.100 mmol) was placed in an NMR tube and dissolved 
in 0.50 mL DMSO. K(B3N3Me6CF3) (0.50 mL 0.20 M stock in DMSO, 0.10 mmol) was then 
added and the NMR tube vigorously shaken. 19F NMR spectra were recorded 10 minutes after CF3
- 
addition and the product peak integrated against 0.3 mmol fluorobenzene internal standard. The 
product conformed to literature spectra of PhSCF3. 
19F NMR (literature (in CDCl3): -42.7):
[25] -
42.33. Yield: 79%. 
Fig. S18. In-Situ 19F NMR Spectrum: 
 
PhSeCF3 
Experimental: Diphenyldiselenide (31.2 mg, 0.100 mmol) was placed in an NMR tube and 
dissolved in 0.50 mL DMSO. K(B3N3Me6CF3) (0.50 mL 0.20 M stock in DMSO, 0.10 mmol) was 
then added and the NMR tube vigorously shaken. 19F NMR spectra were recorded 10 minutes after 
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CF3
- addition and the product peak integrated against 0.30 mmol fluorobenzene internal standard. 
The product conformed to literature spectra of PhSeCF3. 
19F NMR (literature (in CDCl3): -36.6):
[26] 
-36.21 (3F, s). Yield: 69%. 
Fig. S19. In-Situ 19F NMR Spectrum: 
 
 
2-Naphthylmethyl trifluoromethyl sulfide: 
Experimental: Finely powdered elemental sulfur (12.8 mg, 0.400 mmol) was stirred in 10 mL THF 
for one minute to give a light yellow suspension. With vigorous stirring, K(18-crown-
6)(B3N3Me6CF3)(THF) (2.00 mL, 0.2 M in THF, 0.400 mmol) was added. The color immediately 
changed to light green, then after 30 seconds to a deep blue. After 20 minutes, the color disappeared 
to afford a homogeneous solution of K(18-crown-6)SCF3, from which a 30 µL sample was 
removed for analysis by 19F NMR spectroscopy (92% K(18-crown-6)SCF3 in-situ). Bromomethyl 
naphthalene (0.400 mmol, 88.4 mg) was then added to the stirred solution. The solution was stirred 
for 30 minutes, and again sampled and analyzed by 19F NMR spectroscopy (81% 2-
Naphthylmethyl trifluoromethyl sulfide in-situ). The THF solvent was removed by rotary 
evaporation, and the reaction was quenched with 10 mL water and extracted with CH2Cl2 (5 x 2 
mL), the CH2Cl2 extract was evaporated, and the crude solid was purified by flash silica 
chromatography. Chromatography conditions: 100% Hexane, 8 column volumes, 25 g SiO2, flow 
rate 1 column volume per minute. 54.9 mg white solid (57% isolated). 1H-NMR (CDCl3): 7.86 (δ, 
1H, (m, J1H-1H=7.1, 2)), 7.85 (ε, 1H, m (overlap)), 7.83 (θ, 1H, m (overlap)), 7.80 (β, 1H, s), 7.52 
(η, 1H, (m, J1H-1H=7.1, 2)), 7.51 (ζ, 1H, (m, J1H-1H=7.1, 2)), 7.47 (γ, 1H, (dd, J1H-1H=8.4, 1.6)), 4.30 
(α, 2H, s). 13C-NMR: 133.28 (6), 132.85 (7), 132.34 (2), 130.64 (12, q, J13C-19F=307), 128.79 (5), 
127.92 (4), 127.77 (8), 127.74 (9), 126.51 (10), 126.49 (3), 126.37 (11), 34.58 (1, q, J13C-19F=2.3). 
19F-NMR: -45.19 (s). HRMS (EI+): 242.0380  (M+: 242.0377). Note: Use of superstoichiometric 
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sulfur severely reduces the yield of the reaction. The solubility of K(18-crown-6)SCF3 appears to 
be between 0.04 and 0.06 moles/L in 25 °C THF. 
Fig. S20. In-Situ 19F NMR Spectrum of K(18-crown-6)SCF3: 
 
 
Fig. S21. 1H NMR Spectrum: 
 
Fig. S22. 13C NMR Spectrum: 
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Fig. S23. 19F NMR Spectrum: 
 
 
 
Fig. S24. 1H-gCOSY Spectrum:  
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Fig. S25. 1H-13C gHSQCAD Spectrum: 
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Fig. S26. 1H-13C gHMBCAD Spectrum: 
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2-Naphthylmethyl trifluoromethyl selenide: 
 
Experimental: 100 mesh grey elemental selenium (31.2 mg, 0.400 mmol) was stirred in 10 mL 
THF for one minute to give a light brown suspension. With vigorous stirring, K(18-crown-
6)(B3N3Me6CF3)(THF) (2.00 mL, 0.2 M in THF, 0.400 mmol) was added. The color immediately 
changed to a slightly darker brown. After 20 minutes, the reaction was slightly turbid. The amount 
of K(18-crown-6)SeCF3 in solution was assessed through removal of a 30 µL sample,  analyzed 
by 19F NMR spectroscopy (61% K(18-crown-6)SeCF3 in-situ). Bromomethyl naphthalene (88.4 
mg, 0.400 mmol) was then added to the stirred solution. Within one minute a thick, white solid 
precipitated. The solution was stirred for 30 minutes, and again sampled and analyzed by 19F NMR 
spectroscopy (63% 2-naphthylmethyl trifluoromethyl selenide in-situ). The THF solvent was then 
removed by rotary evaporation, and the reaction was quenched with 10 mL water and extracted 
with CH2Cl2 (5 x 2 mL), the CH2Cl2 extract evaporated, and the crude solid was purified by flash 
silica chromatography. Chromatography conditions: 100% Hexane, 8 column volumes, 25 g SiO2, 
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flow rate 1 column volume per minute. 61.2 mg white solid (64% isolated). 1H-NMR (CDCl3): 
7.85 (δ, 1H, (m, overlap)), 7.83 (ε, 1H, m (overlap)), 7.82 (θ, 1H, m (overlap)), 7.80 (β, 1H, s), 
7.51 (η, 1H, (m, overlap)), 7.50 (ζ, 1H, (m, overlap)), 7.47 (γ, 1H, (dd, J1H-1H=8.4, 1.8)), 4.43 (α, 
2H, s). 13C-NMR: 133.39 (6), 132.32 (7), 132.71 (2), 128.81 (5), 127.83 (4), 127.73 (8), 127.72 
(9), 126.76 (10), 126.50 (3), 126.31 (11), 122.87 (12, q, J13C-19F=331), 29.54 (1, q, J13C-19F=1.6). 
19F-NMR: -34.35 (s). 77Se-NMR: 505.92 (q, J77Se-19F=13.5). HRMS (EI+): 289.9821  (M
+: 
289.9822). Notes: Use of superstoichiometric selenium severely reduces the yield of the reaction.  
Fig. S27. In-Situ 19F NMR Spectrum of K(18-crown-6)SeCF3: 
 
Fig. S28. 1H NMR Spectrum: 
 
 
 
 
 
 
Fig. S29. 13C NMR Spectrum: 
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Fig. S30. 19F NMR Spectrum: 
 
Fig. S31. 77Se NMR Spectrum: 
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Fig. S32. 1H-gCOSY Spectrum:  
  
2-Naphthylmethyl trifluoromethyl telluride: 
 
Experimental: Elemental tellurium (51.0 mg, 0.400 mmol) was stirred in 10 mL THF for 10 
minutes to give a suspension. With vigorous stirring, K(18-crown-6)(B3N3Me6CF3)(THF) (2.00 
mL, 0.2 M in THF, 0.400 mmol) was added. The color immediately changed to a light purple. 
After 72 hours, the reaction was slightly turbid and deep purple in color. The amount of K(18-
crown-6)TeCF3 in solution was assessed through removal of a 30 µL sample,  analyzed by 
19F 
NMR spectroscopy (97% K(18-crown-6)TeCF3 in-situ; 
19F NMR: 2.06; 125Te NMR: 207.48 
(J125Te-19F=251.8). Bromomethyl naphthalene (88.4 mg, 0.400 mmol) was then added to the stirred 
solution. Within one minute a thick, white solid precipitated. The solution was stirred for 30 
minutes, and again sampled and analyzed by 19F NMR spectroscopy (88% 2-naphthylmethyl 
trifluoromethyl selenide in-situ). The THF solvent was then removed by rotary evaporation, and 
the reaction was quenched with 10 mL water and extracted with CH2Cl2 (5 x 2 mL), the CH2Cl2 
extract evaporated, and the crude solid was purified by flash silica chromatography. 
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Chromatography conditions: 100% Hexane, 8 column volumes, 25 g SiO2, flow rate 1 column 
volume per minute. 80.1 mg white solid (59% isolated). 1H-NMR (CDCl3): 7.75 (4H, (m, 
overlap)), 7.45 (3H, m (overlap)), 4.69 (2H, s). 19F-NMR: -27.28 (s). MS (EI+): 340.1 (M+: 
339.9719) 
Fig. S33. In-Situ 19F NMR Spectrum of K(18-crown-6)TeCF3: 
 
Fig. S34. In-Situ 125Te NMR Spectrum of K(18-crown-6)TeCF3: 
 
  
S26 
 
Fig. S35. 1H NMR Spectrum: 
 
Fig. S36. 19F NMR Spectrum: 
 
Nucleophilic Trifluoromethylation of Inorganic Compounds with LA-CF3: 
Comparison between 2 and previously reported CF3- sources (1a-c) 
Protocol for reactions with KB(OMe)3CF3:  
To 0.100 mmol of substrate dissolved in 0.50 mL of THF was added 0.100 mmol KB(OMe)3CF3 
as a solution in 0.50 mL THF. Yields were determined by 19F NMR integration against 
fluorobenzene internal standard after 10 minutes at room temperature.  
Protocol for reactions with SiMe3CF3/KF/18-crown-6:  
To 0.100 mmol of substrate dissolved in 0.50 mL of THF was added 0.100 mmol of a 1:1 mixture 
of SiMe3CF3/18-crown-6 as a solution in in 0.5 mL THF. 0.10 mmol KF was then added as a solid, 
and the mixture vigorously shaken for 10 minutes at room temperature. Yields were determined 
by 19F NMR integration against fluorobenzene internal standard.  
Protocol for reactions with KDMF•CF3:  
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To 0.100 mmol of substrate dissolved in 0.50 mL DMF was added 0.100 mmol KDMF•CF3 as a 
solution in 0.50 mL DMF. Both solutions were chilled to -40 °C prior to combination, and the 
reaction mixtures were then rapidly warmed to room temperature (<1 minute) and allowed to react 
for 10 minutes. Yields were determined by 19F NMR integration against fluorobenzene internal 
standard. 
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Fig. S37. Comparison between 2 and previously reported CF3- sources 
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Fig. S38. Disadvantages of previously reported CF3- sources 
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Rapid Electrophilic Trifluoromethylation of Thiols using 2 
1-Trifluoromethylthio-β-D-glucose tetraacetate 
Fig. S39. Reaction Scheme: 
  
Step 1: 
This procedure was reported in our manuscript describing the preparation of 2.[11]  
Hexamethylborazine (0.290 mmol, 47.7 mg) and 18-crown-6 (0.290 mmol, 76.6 mg) were 
dissolved in 1.5 mL THF in a 20 mL flask equipped with a Teflon-coated magnetic stirbar. The 
vessel was then allowed to cool to 0 °C in a glovebox cold-well for 30 minutes. Benzylpotassium 
(0.270 mmol, 35.2 mg) was then quickly added to this cold solution, and the initial deep red color 
of dissolved benzylpotassium quickly changed to a faint purple color. The homogeneous solution 
was stirred for 2 minutes, giving a homogeneous purple solution. The flask was then sealed with 
a tightly belt-clamped septum. Gaseous HCF3 was added to the sealed vessel with a 30 mL syringe 
(0.32 mmol, 8.0 mL) and continuous efficient stirring. The colorless solution was stirred for 2 
minutes, and brought to room temperature. 1 equivalent 1-chloro-3,3-dimethyl-1,3-dihydro-1λ-
benzo[d][1,2]iodaoxole (0.27 mmol, 80 mg) was then added to the reaction mixture, and stirred at 
room temperature for 10 minutes; in this time, a white precipitate appeared. A 60 µL sample was 
removed for analysis by 19F and 1H NMR; conversion to 1-trifluoromethyl-3,3-dimethyl-1,3-
dihydro-1λ-benzo[d][1,2]iodaoxole was 78%, while hexamethylborazine was regenerated (98%). 
The fluorine NMR spectra of the product matched literature spectra (19F-NMR (CDCl3): -40.1).
[27] 
19F-NMR (THF): -41.32 (s). 
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Step 2: 
 
The solvent was removed under vacuum (5 minutes), reconstituted in 1.5 mL acetonitrile, cooled 
to -30 °C (5 minutes), and a -30 °C solution of 1-thio-β-D-glucose tetraacetate (0.270 mmol, 100 
mg) in 1.5 mL acetonitrile quickly added. The reaction was then immediately allowed to warm to 
room temperature and vigorously stirred for 10 minutes (synthesis time: 32 minutes). A 30 µL 
sample was removed for analysis by 19F NMR spectroscopy, the reaction was opened to air, and 
the solvent was removed by rotary evaporation. The white solid was then suspended in 10 mL 
water, and the organic components extracted into dichloromethane (4 x 2 mL). The 
dichloromethane extract was then dried with magnesium sulfate, filtered, concentrated to 2 mL, 
and purified by flash chromatography. Chromatography conditions: 50 g SiO2, 12%-100% ethyl 
acetate/hexanes over 10 column volumes, Rf: 0.58. The product is not UV active, so it was detected 
during elution by means of an attached evaporative light scattering detector (Biotage ELSD-A120; 
settings: nebulizer temperature: 40 °C, evaporation temperature: 60 °C, flow: 2.5). The fractions 
containing 1-trifluoromethylthio-β-D-glucose tetraacetate were combined and evaporated by 
rotary evaporation, then dried under high vacuum (50.4 mg, 43% combined yield from 
benzylpotassium). Time required for isolation: 90 minutes. 1H-NMR (CDCl3): 5.23 (1H, γ, (t, J1H-
1H=9.3)), 5.07 (1H, ε, (t, J1H-1H=9.8)), 5.01 (1H, ß, (t, J1H-1H=9.7)), 4.96 (1H, α, (d, J1H-1H=10.3)), 
4.26 (1H, τ, (dd, J1H-1H=12.5, 5.3)), 4.10 (1H, τ, (dd, J1H-1H=12.4, 2.2)), 3.77 (1H, ζ, (ddd, J1H-
1H=10.1, 5.3, 2.3)). 
13C-NMR: 170.49 (7), 169.90 (7), 169.25 (7), 129.33 (9, q, J13C-19F=308), 81.43 
(1, q, J13C-19F=2.8), 76.24 (5), 73.32 (3), 69.22 (2), 67.76 (4), 61.67 (6), 20.56 (8), 20.47 (8), 20.44 
(8). 19F-NMR: -40.08 (s). HRMS (ESI+): 450.1045 (M+NH4: 450.1040). 
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In-Situ Characterization: 
Fig. S40. In-situ 19F NMR spectrum of 1-trifluoromethyl-3,3-dimethyl-1,3-dihydro-1λ-
benzo[d][1,2]iodaoxole: 
 
Fig. S41. In-situ 1H NMR spectrum of Regenerated Hexamethylborazine: 
 
Fig. S42. In-situ 19F NMR spectrum of 1-Trifluoromethylthio-β-D-glucose tetraacetate: 
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Characterization  of isolated 1-trifluoromethylthio-β-D-glucose tetraacetate: 
Fig. S43. 1H NMR Spectrum: 
 
Fig. S44. 13C NMR Spectrum: 
 
Fig. S45. 19F NMR Spectrum: 
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Fig. S46. 1H-1H gCOSY NMR Spectrum: 
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Fig. S47. 1H-13C gHSQCAD NMR Spectrum: 
 
Nucleophilic Trifluoromethylation of Organic Compounds with LA-CF3: 
Initial Condition Screening 
To 0.1 mmol of substrate dissolved in 0.50 mL DMSO or THF was added one of the above stock 
solutions of the HCF3 derived CF3
- reagent. NMR spectra were recorded at 30 minute, 1 hour, 5 
hour, and 24 hour time points to monitor conversion to trifluoromethylated product through 
integration against a 0.030 mmol fluorobenzene internal standard. In cases where anionic addition 
products were observed, confirmation of product identity was made through GCMS.  
 
 
 
 
 
 
 
S36 
 
Fig. S48. Optimization Table
S37 
 
 
Fig. S49. Optimization Table Cont. 
 
Nucleophilic Trifluoromethylation of Organic Compounds with LA-CF3: 
Isolated Compounds and Characterization 
General Protocol:  
An appropriate quantity of a 0.2 M stock solution of K(LA-CF3) was added to a 0.2 M solution of 
substrate in a 20 mL scintillation vial. The mixture was then stirred for the specified time (vide 
infra) then quenched by adding 15 mL of 5% aqueous HCl or saturated aqueous ammonium 
chloride. The product was then extracted into CH2Cl2 (5 x 3 mL CH2Cl2) and the organic phase 
dried with MgSO4. The dried organic phase was then filtered, concentrated to 1 mL, then purified 
by silica chromatography using a Biotage Isolera automated flash chromatography apparatus. The 
collected fractions were concentrated by rotary evaporation and further dried under high vacuum 
to afford the pure products. 
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1,2 Addition Reactions with C=O and C=N compounds 
 
1-Phenyl-1-trifluoromethylmethanol: 
Substrate: Benzaldehyde. Conditions: Solvent: DMSO. LA: K(BOCH2CH2N)3CF3. 1.0 
equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 1 hour. Quench: 5% HCl.  
Chromatography conditions: 100% CH2Cl2, 9 column volumes, 10g SiO2, flow rate: 1 column 
volume per minute. 62 mg colorless oil, 88%. Due to the volatile nature of the product it could not 
be dried under high vacuum. 1H-NMR (CDCl3): 7.46 (ß, 2H, m), 7.41 (α, γ, 3H, m), 4.98 (ε, 1H, 
(q, J1H-19F=6.7)), 2.88 (ζ, 1H, s). 13C-NMR: 133.92, 129.53, 128.60, 127.41, 124.22 (q, J13C-
19F=282), 72.79 (q, J13C-19F=32). 
19F-NMR: -78.36 (d, J19F-1H=6.7).  HRMS (ESI-): 221.0435 
(M+HCO2: 221.0431). 
Fig. S50. 1H NMR Spectrum: 
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Fig. S51. 13C NMR Spectrum: 
 
Fig. S52.  19F NMR Spectrum: 
 
 
Methyl 4-(trifluoro-1-ethanol)benzoate 
Substrate: Methyl 4-formyl benzoate. Conditions: Solvent: DMSO.  LA: K(BOCH2CH2N)3CF3. 
1.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 1 hours. Quench: 5% HCl.  
Chromatography conditions: 0-100% hexane/ethyl acetate, 16 column volumes, 50 g SiO2, flow 
rate 0.5 column volume per minute. 56 mg white solid, 60%. 1H-NMR (CDCl3): 8.00 (ß, 2H, (d, 
J1H-1H=8.1)), 7.54 (γ, 2H, (d, J1H-1H=7.9)), 5.08 (ε, 1H, (q, J1H-19F=6.7)), 3.89 (α, 3H, s), 3.72 (ζ, 
1H, s). 13C-NMR: 167.00, 139.02, 130.83, 129.69, 127.51, 124.02 (q, J13C-19F=282), 72.25 (q, J13C-
19F=32), 52.39. 
19F-NMR: -78.18 (d, J19F-1H=6.7).  HRMS (ESI-): 235.0573 (M-H: 235.0577). 
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Fig. S53. 1H NMR Spectrum: 
 
 
Fig. S54. 13C NMR Spectrum: 
 
Fig. S55.  19F NMR Spectrum: 
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4-(Trifluoro-1-ethanol)benzonitrile 
Substrate: 4-formyl-benzonitrile. Conditions: Solvent: DMSO.  LA: K(BOCH2CH2N)3CF3. 1.0 
equivalent K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 1 hours. Quench: 5% HCl.  
Chromatography conditions: 0-100% CH2Cl2/ethyl acetate, 8 column volumes, 10 g SiO2, flow 
rate 1 column volume per minute. 39 mg white solid, 48%. 1H-NMR (CDCl3): 7.68 (ß, 2H, (d, J1H-
1H=8.2)), 7.63 (α, 2H, (d, J1H-1H=8.1)), 5.11 (γ, 1H, (p, J1H-19F=6.2)), 3.44 (ε, 1H, (d, J1H-1H=4.6))). 
13C-NMR: 139.19, 132.28, 128.27, 123.78(q, J13C-19F=282), 118.27, 112.94, 72.25 (q, J13C-19F=32). 
19F-NMR: -78.18 (d, J19F-1H=6.4).  HRMS (ESI-): 200.0322 (M-H: 200.0329). 
Fig. S56. 1H NMR Spectrum: 
 
Fig. S57. 13C NMR Spectrum: 
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Fig. S58.  19F NMR Spectrum: 
 
 
1-(Anthracen-9-yl)-1,1-bistrifluoromethylcarbinol 
Substrate: Anthracen-9-yl trifluoromethyl ketone. Conditions: Solvent: THF.  LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 2.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 1 
hour. Quench: 5% HCl.  Chromatography conditions: 0-100% hexane ethyl acetate, 16 column 
volumes, 25 g SiO2, flow rate 1 column volume per minute. 120 mg yellow crystals, 87%. 
1H-
NMR (CDCl3): 9.02 (α, 1H, (d, J1H-1H=9.3)), 8.55 (α, 1H, (d, J1H-1H=9.3)), 8.51 (γ, 1H, s), 7.99 (ß, 
2H, (t, J1H-1H=9.5)), 7.59 (ß, 1H, (t, J1H-1H=8.3)), 7.49 (α, ß, 3H, m), 3.98 (ε, 1H, s). 13C-NMR: 
134.06, 133.11, 132.46, 132.41, 131.38, 131.15, 129.39, 129.11, 127.34, 126.71, 125.98, 124.78, 
124.61, 123.94(q, J13C-19F=290), 121.94, 83.46(p, J13C-19F=31). 
19F-NMR: -69.31 (s). HRMS (ES+): 
344.0630 (M+: 344.0636).  
Fig. S59. 1H NMR Spectrum: 
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Fig. S60. 13C NMR Spectrum (1H decoupled): 
 
 
Fig. S61. 13C NMR Spectrum (19F decoupled): 
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Fig. S62.  19F NMR Spectrum: 
 
1-(Trans)-phenylethenyl-1-phenyl-trifluoromethylcarbinol 
Substrate: Trans-chalcone. Conditions: Solvent: THF.  LA: K(18-crown-6)(B3N3Me6CF3)(THF). 
1.0 equivalents K(LA-CF3) used. 0.80 mmol substrate. Reaction time: 10 minutes. Quench: 5% 
HCl.  Chromatography conditions: 0-100% hexane ethyl acetate, 16 column volumes, 25 g SiO2, 
flow rate 1 column volume per minute. 190 mg colorless oil, 84%. 1H-NMR (CDCl3): 7.69 (ß, 2H, 
(d, J1H-1H=7.7)), 7.45 (ß, α, 5H, m), 7.38 (ß, 2 H, (t, J1H-1H=7.4)), 7.33 (α, 1H, (t, J1H-1H=7.3)), 6.91 
(γ, 1H, (d, J1H-1H=16.1)), 6.77 (γ, 1H, (d, J1H-1H=16.1)), 2.79 (ε, 1H, s). 13C-NMR: 137.40, 135.51, 
133.58, 128.84, 128.76, 128.67, 128.41, 126.95, 126.84, 126.46, 125.08(q, J13C-19F=286), 77.34(q, 
J13C-19F=29). 
19F-NMR: -78.46 (s).  HRMS (EI+): 278.0919(M+: 278.0918). 
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Fig. S63. 1H NMR Spectrum: 
 
 
Fig. S64. 13C NMR Spectrum: 
 
Fig. S65.  19F NMR Spectrum: 
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1-Phenylethynyl-1-phenyl-trifluoromethylcarbinol 
Substrate: Diphenylpropynone. Conditions: Solvent: THF.  LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 1.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 16 
hours. Quench: saturated NH4Cl.  Chromatography conditions: 0-30% hexane ethyl acetate, 16 
column volumes, 50 g SiO2, flow rate 1 column volume per minute. 45 mg orange oil, 42%. 
1H-
NMR (CDCl3): 7.83 (ß, 2H, (d, J1H-1H=4.8)), 7.56 (ß, 2H, (d, J1H-1H=4.8)), 7.46 (α, ß, 3H, m), 7.42 
(α, 1H, (p, J1H-1H=7.4)), 7.37 (ß, 2H, (t, J1H-1H=7.4)), 3.15 (ε, 1H, s). 13C-NMR:135.26, 132.06, 
129.55, 129.53, 128.47, 128.25, 127.19, 123.39(q, J13C-19F=286), 120.93, 88.09, 84.40, 73.36(q, 
J13C-19F=33). 
19F-NMR: -80.29 (s). HRMS (ESI-): 275.0683(M-H: 275.0684).  
Fig. S66. 1H NMR Spectrum: 
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Fig. S67. 13C NMR Spectrum: 
 
Fig. S68.  19F NMR Spectrum: 
 
 
N-tosyl-1-trifluoromethyl-benzylamine 
Substrate: N-tosylbenzaldimine. Conditions: Solvent: DMSO.  LA: K(BOCH2CH2N)3CF3. 1.0 
equivalent K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 1 hours. Quench: saturated 
NH4Cl.  Chromatography conditions: 0-100% hexane/CH2Cl2, then 0-100% CH2Cl2/ethyl acetate, 
16 column volumes, 25 g SiO2, flow rate 1 column volume per minute. 86 mg white solid, 65%. 
1H-NMR (CDCl3): 7.60 (ß, 2H, (d, J1H-1H=8.2)), 7.18 (ß, α, 7H, m), 6.16 (ε, 1H, (d, J1H-1H=9.1)), 
4.91 (γ, 1H, (p, J1H-19F=7.7)), 2.34 (η, 3H, s). 13C-NMR: 143.74, 136.89, 131.79, 129.46, 129.19, 
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128.74, 127.76, 126.92, 123.89(q, J13C-19F=282), 59.18(q, J13C-19F=32), 21.43. 
19F-NMR: -74.02 (d, 
J19F-1H=7.4).  HRMS (ESI-): 328.0624(M-H: 328.0625). 
Fig. S69. 1H NMR Spectrum: 
 
 
Fig. S70. 13C NMR Spectrum: 
 
Fig. S71.  19F NMR Spectrum: 
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1,1-bistrifluoromethyl-1-(4-phenyl)phenyl-methanol: 
Substrate: Biphenyl-4-carbonyl chloride. Conditions: Solvent: THF.  LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 2.2 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 16 
hours. Quench: 5% HCl. Chromatography conditions: 0-20% Hexane/Ethyl acetate, 8 column 
volumes, 25 g SiO2, flow rate 1 column volume per minute. 107 mg white solid, 84%. 
1H-NMR 
(CDCl3): 7.82 (ε, 2H, (d, J1H-1H=8.1)), 7.71 (δ, 2H, (d, J1H-1H=8.2)), 7.64 (γ, 2H, (d, J1H-1H=7.8)), 
7.49 (ß, 2H, (t, J1H-1H=7.5)), 7.41 (α, 1H, (t, J1H-1H=7.3)), 3.38 (ζ, 1H, s).  13C-NMR:143.16, 139.88, 
128.90, 128.06, 127.94, 127.30, 127.20, 126.94, 122.65(q, J13C-19F=288), 77.18 (p, J13C-19F=30.3) 
(overlap with CDCl3). 
19F-NMR: -75.58 (s). HRMS (ES+): 320.0636 (M-C3H7
+: 320.0636).  
Fig. S72. 1H NMR Spectrum: 
 
Fig. S73. 13C NMR Spectrum: 
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Fig. S74. 19F NMR Spectrum: 
 
Fig. S75. 1H- 1H gCOSY Spectrum: 
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Fig. S76. 1H- 13C gHSQCAD Spectrum: 
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Fig. S77. 1H- 13C gHMBCAD Spectrum: 
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Fig. S78. 19F- 13C gHSQCAD Spectrum: 
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Fig. S79. 19F- 13C gHMBCAD Spectrum: 
 
 
Trifluoromethyl-(4-phenyl)phenyl Ketone: 
Substrate: Methyl biphenyl-4-carboxylate. Conditions: Solvent: THF. LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 1.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 30 
minutes. Quench: 5% HCl.  Chromatography conditions: 0-100% Hexane/Ethyl acetate, 8 column 
volumes, 25 g SiO2, flow rate 1 column volume per minute. 29 mg white solid, 29%. 
1H-NMR 
(CDCl3): 8.17 (ε, 2H, (d, J1H-1H=8.0)), 7.78 (δ, 2H, (d, J1H-1H=8.4)), 7.66 (γ, 2H, (d, J1H-1H=7.1)), 
7.51 (ß, 2H, (t, J1H-1H=7.6)), 7.45 (α, 1H, (t, J1H-1H=7.4)). 13C-NMR: 180.07 (q, J13C-19F=35.0), 
148.21, 139.11, 130.72, 129.11, 128.89, 128.56, 127.63, 127.34, 116.76 (q, J13C-19F=291),. 
19F-
NMR: -71.35 (s). HRMS (ES+): 250.0611 (M+: 250.0605).  
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Fig. S80. 1H NMR Spectrum: 
 
Fig. S81. 13C NMR Spectrum: 
 
Fig. S82. 19F NMR Spectrum: 
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Triisopropylsilyl Hexafluoro-2-phenoxypropan-2-ol 
Substrate: Diphenylcarbonate. Conditions: Solvent: THF. LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 2.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 30 
minutes. Quench: 2.0 equivalents triisopropylsilyl chloride were added, then the reaction stirred 
for 16 hours at 25 °C. The reaction mixture was then quenched with 10 mL water.  
Chromatography conditions: 100% Hexane, 4 column volumes, 100 g SiO2, flow rate 0.5 column 
volume per minute; chromatography was repeated six times to remove triisopropylsilyl phenol. 
102 mg colorless oil, 61%. Boiling point: 65 °C at 0.080 Torr. 1H-NMR (CDCl3): 7.32 (ß, 2H, (t, 
J1H-1H=8.4)), 7.19 (α, 3H, m), 1.14 (γ, 3H, m), 1.05 (ε, 18H, (d, J1H-1H=7.2)).  13C-NMR:151.46, 
129.07, 125.80, 123.58, 120.73(q, J13C-19F=293), 95.20 (p, J13C-19F=32.8), 17.43, 13.07. 
19F-NMR: 
-76.97 (s). HRMS (ES+): 373.1061 (M-C3H7
+: 373.1059).  
Fig. S83. 1H NMR Spectrum: 
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Fig. S84. 13C NMR Spectrum: 
 
Fig. S85. 19F NMR Spectrum: 
 
 
Phenyl trifluoroacetamide 
Substrate: Phenyl isocyanate. Conditions: Solvent: THF. LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 1.0 equivalents K(LA-CF3) used. 0.80 mmol substrate. Reaction time: 1 
hour. Quench: 5% HCl.  Chromatography conditions: 10-50% hexane/CH2Cl2, 8 column volumes, 
25 g SiO2, flow rate 1 column volume per minute. 91 mg white solid, 61%. 
1H-NMR (CDCl3): 
8.03 (ε, 1H, s), 7.54 (γ, 2H, (d, J1H-1H=7.7)), 7.46 (ß, 2H, (t, J1H-1H=8.0), 7.23 (α, 1H, (t, J1H-
1H=7.4)). 
13C-NMR: 154.87(q, J13C-19F=37), 135.04, 129.33, 126.39, 120.56, 115.72(q, J13C-
19F=288). 
19F-NMR: -75.80 (s). HRMS (ES+): 189.0401 (M+: 189.0401). 
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Fig. S86. 1H NMR Spectrum: 
 
 
 
Fig. S87. 13C NMR Spectrum: 
 
Fig. S88.  19F NMR Spectrum: 
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Nucleophilic Aromatic Substitution 
 
Perfluoro-p-xylene 
Substrate: Perfluorotoluene. Conditions: Solvent: THF. LA: K(18-crown-6)(B3N3Me6CF3)(THF). 
1.0 equivalents K(LA-CF3) used. 0.10 mmol substrate. Reaction time: 10 min. Quench: water.  
Characterized in-situ; yield determined by 19F-NMR spectroscopy and integrated against 0.030 
mmol fluorobenzene. The product spectrum closely matched the literature chemical shifts and 19F-
19F coupling constants. Because of highly complex coupling, spin simulation in MestReNova was 
performed using the literature coupling constants to provide comparison with the experimental in-
situ spectrum. (Literature 19F-NMR (solvent not specified): -57.6 (J19F-19F = 22.7 (α-(β/ζ), ω-(ε/γ)), 
0.4 (α-(ε/γ), ω-(β/ζ)), -138.9 (J19F-19F=18.6 (β-ε, ζ-γ), 13.2 (β-γ, ζ-ε))).[28] Chemical yield: 27%. In-
Situ 19F-NMR: -56.46 (α, ω 6F, m), -139.38 (β, ε, γ, ζ, 4F, m) 
Fig. S89.  19F NMR Spectrum: 
 
*: Perfluorotoluene 
  
* 
* 
* 
* 
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Fig. S90. Superimposed Simulated (gray; from literature J-couplings) and Experimental 
(black; from in-situ generation of perfluoro-p-xylene) 19F NMR Spectra for -CF3 and –F 
Peaks: 
                                 
 
 
1-Trifluoromethyl-4-nitrobenzene 
Substrate: 1,4-Dinitrobenzene. Conditions: Solvent: THF. LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 1.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 2 
hour. Quench: water.  Chromatography conditions: 0-100% Hexane/CH2Cl2, 8 column volumes, 
25 g SiO2, flow rate 1 column volume per minute. 64 mg white solid, 42%. 
1H-NMR (CDCl3): 
8.34 (α, 2H, (d, J1H-1H=8.4)), 7.84 (α, 2H, (d, J1H-1H=8.5)).  13C-NMR: 150.00, 136.06 (q, J13C-
19F=33), 126.77 (q, J13C-19F=3), 124.07, 122.94(q, J13C-19F=273), 73.36(q, J13C-19F=33). 
19F-NMR: -
63.19 (s). HRMS (ES+): 191.0195 (M+: 191.0194). 
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Fig. S91. 1H NMR Spectrum: 
 
 
Fig. S92. 13C NMR Spectrum: 
 
Fig. S93.  19F NMR Spectrum: 
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5-Phenyl-2-Trifluoromethylpyridine: 
Substrate: 5-Phenyl-2-nitropyridine. Conditions: Solvent: THF. LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 1.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 2 
hours. Quench: 10 mL water.  Chromatography conditions: 0-30% Hexane/Ethyl acetate, 8 column 
volumes, 25 g SiO2, flow rate 1 column volume per minute. 30 mg white solid, 33%. 
1H-NMR 
(CDCl3): 8.94 (α, 1H, s), 8.04 (ß, 1H, (d, J1H-1H=8.1)), 7.76 (ß, 1H, (d, J1H-1H=8.1)), 7.60 (γ, 2H, 
(d, J1H-1H=8.1)), 7.53 (δ, 2H, (t, J1H-1H=8.1)), 7.46 (ε, 1H, (t, J1H-1H=6.8)). 13C-NMR: 148.46, 146.77 
(q, J13C-19F=34.7), 139.48, 136.35, 135.48, 129.32, 129.00, 127.33, 121.69 (q, J13C-19F=273), 120.43 
(q, J13C-19F=2.7). 
19F-NMR: -71.38 (s). HRMS (ESI+): 224.0679 (M+H: 224.0682).  
Fig. S94. 1H NMR Spectrum: 
 
Fig. S95. 13C NMR Spectrum: 
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Fig. S96. 19F NMR Spectrum: 
 
Direct Nucleophilic Addition/Oxidation 
  and    
6-Phenyl-(2-/4-)trifluoromethylpyrimidine: 
6-Phenylpyrimidine (93.7 mg, 0.600 mmol) was dissolved in 3 mL THF. K(18-crown-
6)(B3N3Me6CF3)(THF) (3.00 mL, 0.2 M in THF, 0.600 mmol) was then added. After 72 hours, 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (135 mg, 0.600 mmol) was added and the mixture 
stirred for five minutes. NMR spectra showed a mixture of two trifluoromethylated products.  The 
reaction mixture was quenched with water. The aqueous phase was extracted with CH2Cl2 (5 x 2 
mL), the CH2Cl2 extract was dried and concentrated, and the crude oil was purifed by flash silica 
chromatography. Chromatography conditions: 0-40% Hexane/DCM, 12 column volumes, 25 g 
SiO2, flow rate 1 column volume per minute. Chromatography afforded separated -2 and -4 
substituted products. 6-Phenyl-2-trifluoromethylpyrimidine: 9.2 mg white solid, 7%. 1H-NMR 
(CDCl3): 8.91 (ß, 1H, (d, J1H-1H=5.3)), 8.17 (γ, 2H, (dd, J1H-1H=8.1, 1.4)), 7.88 (α, 1H, (d, J1H-
1H=5.3)), 7.57 (ε, 1H, m), 7.55 (δ, 2H, m) 13C-NMR: 165.28, 158.30, 157.05 (q, J13C-19F=36.5), 
135.04, 132.04, 129.22, 127.45, 119.63 (q, J13C-19F=275), 118.23 
19F-NMR: -70.65 (s). HRMS 
(ESI+): 225.0635 (M+H: 225.0640). 6-Phenyl-4-trifluoromethylpyrimidine: 39.5 mg white solid, 
29%. 1H-NMR (CDCl3): 9.39 (α, 1H, s), 8.15 (γ, 2H, (d, J1H-1H=6.9)), 8.03 (ß, 1H, s), 7.58 (ε, 1H, 
m), 7.55 (δ, 2H, m) 13C-NMR: 166.51, 159.40, 156.16 (q, J13C-19F=36.0), 135.34, 132.10, 129.26, 
127.40, 120.66 (q, J13C-19F=275), 112.54 
19F-NMR: -73.70 (s). HRMS (ESI+): 225.0635 (M+H: 
225.0640). 
6-Phenyl-2-trifluoromethylpyrimidine: 
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Fig. S97. 1H NMR Spectrum: 
 
Fig. S98. 13C NMR Spectrum: 
 
 
 
Fig. S99. 19F NMR Spectrum: 
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Fig. S100. 1H-1H gCOSY Spectrum: 
 
 
 
  
S66 
 
Fig. S101. 1H-13C gHSQCAD Spectrum: 
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Fig. S102. 1H-13C gHMBCAD Spectrum: 
 
6-Phenyl-4-trifluoromethylpyrimidine: 
Fig. S103. 1H NMR Spectrum: 
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Fig. S104. 13C NMR Spectrum: 
 
Fig. S105. 19F NMR Spectrum: 
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Fig. S106. 1H-1H gCOSY Spectrum: 
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Fig. S107. 1H-13C gHSQCAD Spectrum: 
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Fig. S108. 1H-13C gHMBCAD Spectrum: 
 
 
4-Trifluoromethylquinazoline: 
Quinazoline (78 mg, 0.600 mmol) was dissolved in 3 mL THF. K(18-crown-
6)(B3N3Me6CF3)(THF) (3.00 mL, 0.2 M in THF, 0.600 mmol) was then added. After 1 hour, 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (135 mg, 0.600 mmol) was added and the mixture stirred 
for one hour. NMR spectra showed a single product.  The reaction mixture was quenched with 
water. The aqueous phase was extracted with CH2Cl2 (5 x 2 mL), the CH2Cl2 extract was dried 
and concentrated, and the crude oil was purifed by flash silica chromatography. Chromatography 
conditions: 0-20% Hexane/Ethyl Acetate, 16 column volumes, 25 g SiO2, flow rate 1 column 
volume per minute. 4-Trifluoromethylquinazoline: 64.0 mg yellow oil, 53%. 1H-NMR (CDCl3): 
9.44 (α, 1H, s), 8.25 (ß, 1H, (d, J1H-1H=8.5)), 8.18 (ε, 1H, (d, J1H-1H=8.5)), 8.03 (δ, 1H, (t, J1H-
1H=8.3)), 7.55 (γ, 1H, (t, J1H-1H=7.7)). 13C-NMR: 154.57 (q, J13C-19F=34.9), 153.50, 151.86, 134.88, 
129.50, 129.40, 124.27 (q, J13C-19F=2.7), 121.24 (q, J13C-19F=277), 120.28
19F-NMR: -64.55 (s). 
HRMS (ESI+): 199.0478 (M+H: 199.0483). 
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Fig. S109. 1H NMR Spectrum: 
 
Fig. S110. 13C NMR Spectrum: 
 
Fig. S111. 19F NMR Spectrum: 
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Fig. S112. 1H-1H gCOSY Spectrum: 
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Fig. S113. 1H-13C gHSQCAD Spectrum: 
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Fig. S114. 1H-13C gHMBCAD Spectrum: 
 
 
 
4-Trifluoromethyl-5-bromo-2-chloro-pyrimidine: 
5-Bromo-2-chloro-pyrimidine (154 mg, 0.800 mmol) was dissolved in 4 mL THF. K(18-crown-
6)(B3N3Me6CF3)(THF) (4.00 mL, 0.2 M in THF, 0.800 mmol) was then added. After 5 minutes, 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (135 mg, 0.600 mmol) was added and the mixture 
stirred for one hour. NMR spectra showed a single product.  The reaction mixture was quenched 
with water. The aqueous phase was extracted with CH2Cl2 (5 x 2 mL), the CH2Cl2 extract was 
dried and concentrated, and the crude oil was purifed by flash silica chromatography. 
Chromatography conditions: 0-20% Hexane/DCM, 12 column volumes, 25 g SiO2, flow rate 1 
column volume per minute. 4-Trifluoromethyl-5-bromo-2-chloro-pyrimidine: 102.3 mg colorless 
oil, 49%. 1H-NMR (CDCl3): 8.94 (α, 1H, s). 13C-NMR: 164.56, 159.61, 155.21 (q, J13C-19F=36.7), 
119.28 (q, J13C-19F=277), 115.35 
19F-NMR: -68.22 (s). HRMS (EI+): 259.8966 (M+: 259.8964). 
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Fig. S115. 1H NMR Spectrum: 
 
Fig. S116. 13C NMR Spectrum: 
 
Fig. S117. 19F NMR Spectrum: 
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Fig. S118. 1H-13C gHSQCAD Spectrum: 
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Fig. S119. 1H-13C gHMBCAD Spectrum: 
 
 
4-Trifluoromethyl-2-6-diphenyltriazine: 
2-6-Diphenyltriazine[29] (0.4 mg, 0.800 mmol) was dissolved in 2 mL THF. K(18-crown-
6)(B3N3Me6CF3)(THF) (4.00 mL, 0.2 M in THF, 0.800 mmol) was then added. After 5 minutes, 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (135 mg, 0.600 mmol) was added and the mixture 
stirred for one hour. NMR spectra showed a single product.  The reaction mixture was quenched 
with water. The aqueous phase was extracted with CH2Cl2 (5 x 2 mL), the CH2Cl2 extract was 
dried and concentrated, and the crude oil was purifed by flash silica chromatography. 
Chromatography conditions: 2-15% Hexane/DCM, 8 column volumes, 25 g SiO2, flow rate 1 
column volume per minute. 4-Trifluoromethyl-5-bromo-2-chloro-pyrimidine: 52.5 mg white 
solid, 43%. 1H-NMR (CDCl3): 8.69 (α, 4H, (d, J1H-1H=8.4)), 7.66 (γ, 2H, (t, J1H-1H=7.3)), 7.58 (ß, 
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4H, (t, J1H-1H=7.7)). 
13C-NMR: 173.07, 165.19 (q, J13C-19F=37.7), 134.43, 133.73, 129.41, 128.90, 
119.07 (q, J13C-19F=277) 
19F-NMR: -72.28 (s). HRMS (ESI+): 302.0897 (M+H: 302.0905). 
Fig. S120. 1H NMR Spectrum: 
 
 
Fig. S121. 13C NMR Spectrum: 
 
Fig. S122. 19F NMR Spectrum: 
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Geminal Bistrifluoromethylations 
 
4,4-Bistrifluoromethyl-2-chloro-3-hydroquinazoline 
Substrate: Dichloroquinazoline. Conditions: Solvent: THF. LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 1.5 equivalents K(LA-CF3) used. 0.80 mmol substrate. Reaction time: 30 
minutes. Quench: 10 mL 5% NaOH, then brought to pH 7 with glacial acetic acid.  
Chromatography conditions: 0-100% hexane/ethyl acetate, 16 column volumes, 25 g SiO2, flow 
rate 1 column volume per minute.146 mg light yellow solid, 60%. 1H-NMR (CDCl3): 8.22 (η, 1H, 
s), 7.58 (α, 1H, (d, J1H-1H=8.0)), 7.41 (ε, 1H, (t, J1H-1H=7.7), 7.22 (ß, 1H, (t, J1H-1H=7.7)), 6.88 (ζ, 
1H, (d, J1H-1H=8.0)). 
13C-NMR: 145.84 (3), 135.58 (4), 131.34 (6), 128.19 (8), 125.66 (7), 
122.42(1, q, J13C-19F=288), 115.09 (5), 108.67 (9), 73.36(2, p, J13C-19F=29). 
19F-NMR: -73.73 (s). 
HRMS (ESI+): 303.0114 (M+H: 303.0124).  
The trifluoromethyl groups were assigned based on crosspeaks in 2D NMR experiments and a 
septet for carbon #2 in the 13C NMR spectrum. HSQC was used to identify the carbon atoms 
associated with hydrogen atoms α, ß, ε, and ζ. 19F-13C HMBC was then used to identify one bond 
coupling with carbon 1, two bond coupling with carbon 2, four bond coupling with carbon 3, and 
four bond coupling with carbon 8. Carbon 3 was assigned based on its lack of long-range coupling 
with any protons and high shift. The positions of carbons 9 and 4 were assigned based on their 
long-range coupling with hydrogen atoms α, ß, ε, and ζ. The position of carbon 8 was based on its 
proximity to the 19F group. Finally, the position of acidic hydrogen η and confirmation of the 
assignment was obtained through single-crystal X-Ray diffraction. A single crystal was obtained 
by allowing a concentrated solution of 4,4-Bistrifluoromethyl-2-chloro-3-hydroquinazoline in 
chloroform to slowly evaporate. 
Fig. S123. 1H NMR Spectrum: 
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Fig. S124. 13C NMR Spectrum: 
 
Fig. S125. 19F NMR Spectrum: 
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Fig. S126. 19F-13C Crisis2 HMBC Spectrum: 
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Fig. S127. 1H- 13C gHMBCAD Spectrum: 
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Fig. S128. 1H- 13C gHSQCAD Spectrum: 
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Fig. S129. 1H- 1H gCOSY Spectrum: 
 
 
2,4-Phenoxy-6,6-bistrifluoromethyl-3-hydro-triazine 
Substrate: 2,4-diphenoxy-6-chlorotriazine. Solvent: THF. Conditions: LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 2.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 2 
hour. Quench: water.  Chromatography conditions: 0-50% Hexane/Ethyl acetate, 8 column 
volumes, 25 g SiO2, flow rate 1 column volume per minute. 123 mg white solid, 76%. 
1H-NMR 
(DMSO-d6): 12.36 (ε, 1H, s), 7.84 (ß, 2H, (t, 4H, (t, J1H-1H=7.8)), 7.27 (α, 2H, (t, J1H-1H=7.3)), 7.21 
(γ, 4H, (d, J1H-1H=8.0)).  13C-NMR (DMSO-d6): 155.74, 151.04, 130.12, 126.60, 122.09(q, J13C-
19F=288), 121.63, 81.02 (p, J13C-19F=29.5). 
19F-NMR: -79.44 (s). HRMS (ES+): 403.0759 (M+: 
403.0755).  
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Fig. S130. 1H NMR Spectrum:  
 
Fig. S131. 13C NMR Spectrum: 
 
Fig. S132.  19F NMR Spectrum: 
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2,4-Phenoxy-6,6-bistrifluoromethyl-3-benzyl-triazine 
Substrate: 2,4-diphenoxy-6-chlorotriazine. Conditions: Solvent: THF. LA: K(18-crown-
6)(B3N3Me6CF3)(THF). 2.0 equivalents K(LA-CF3) used. 0.40 mmol substrate. Reaction time: 30 
minutes. Quench: 1 equiv. benzyl bromide was added under nitrogen, then the reaction stirred for 
16 hours at 25 °C. The reaction mixture was then quenched with 10 mL water.  Chromatography 
conditions: 0-100% Hexane/Ethyl acetate, 16 column volumes, 25 g SiO2, flow rate 1 column 
volume per minute. 108 mg white solid, 55%. 1H-NMR (CDCl3): 7.37 (α, 10H, m), 7.24 (ε, 2H, (t, 
J1H-1H=7.4)), 7.11 (γ, 3H, m), 5.21 (ß, 2H, s).  13C-NMR: 153.07, 151.25, 136.53, 129.33, 128.92, 
127.95, 126.86, 126.02, 121.59(q, J13C-19F=288), 121.11, 78.83(p, J13C-19F=30.3), 46.00. 
19F-NMR: 
-80.41 (s). HRMS (ES+): 493.1229 (M+: 493.1225).  
Fig. S133. 1H NMR Spectrum: 
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Fig. S134. 13C NMR Spectrum: 
 
 
 
Fig. S135. 19F NMR Spectrum: 
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1-benzyl-6-chloro-2-(phenylthio)-4,4-bis(trifluoromethyl)-1,4-dihydroquinazoline: 
Substrate: Trichloroquinazoline. Experimental: Trichloroquinazoline (0.400 mmol, 93.4 mg) was 
combined with 2 equivalents K(18-crown-6)(B3N3Me6CF3)(THF) (0.800 mmol, 4.00 mL, 0.2M 
solution in THF) and stirred for 30 minutes at 25 °C. One equivalent benzyl bromide (0.400 mmol, 
68.4 mg) was then added, and the mixture stirred at 70 °C for 24 hours. The reaction was then 
cooled to 25 °C, and 1 equivalent sodium thiophenolate (0.400 mmol, 52.8 mg) was added. The 
reaction was then heated to 70 °C and stirred for 24 hours. The THF solvent was then removed by 
rotary evaporation, and the crude solid purified by flash chromatography (conditions: 25g SiO2 
column, 0-50% CH2Cl2/Hexane over 16 column volumes at a flow rate of 1 column volume per 
minute) to afford 120 mg of white solid (60%). 1H-NMR (CDCl3): 7.55 (η, 2H, overlap), 7.54 (1H, 
α, overlap), 7.41 (5H, χ, τ, ζ, overlap), 7.34 (1H, σ, (t, J1H-1H=7.4)), 7.28 (2H, ε, (d, J1H-1H=7.7)), 
7.24 (1H, (d(d), (J1H-1H=8.8, 2.1)), 6.75 (1H, γ, (d, J1H-1H=9.0)), 5.27 (2H, δ, s). 13C-NMR: 158.99, 
136.80, 135.69, 134.95, 130.81, 129.48, 129.37, 129.21, 128.73, 128.08, 127.93, 125.76, 122.46 
(q, J13C-19F=288), 115.67, 113.23, 66.80(p, J13C-19F=28.7), 50.36. 
19F-NMR: -73.92 (s). HRMS 
(ESI+): 501.0619 (M+H: 501.0621). A single crystal was obtained for X-Ray diffraction by 
allowing a concentrated solution in chloroform to slowly evaporate. 
Fig. S136. 1H NMR Spectrum: 
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Fig. S137. 13C NMR Spectrum: 
 
Fig. S138. 19F NMR Spectrum: 
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Fig. S139. 1H- 1H gCOSY Spectrum: 
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Fig. S140. 1H- 13C gHSQCAD Spectrum: 
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Fig. S141. 1H- 13C gHMBCAD Spectrum: 
 
Selective 2- or 4- C-H trifluoromethylation of Quinolines 
 
4-Trifluoromethylquinoline: 
Experimental: Quinoline (51.6 mg, 0.400 mmol) was dissolved in 2 mL THF along with B(C6F5)3 
(204 mg, 0.400 mmol). This was cooled to -30 °C, and combined with K(18-crown-
6)(B3N3Me6CF3)(THF) (2.00 mL, 0.2 M in THF, 0.400 mmol) with stirring. The reaction was 
allowed to warm to room temperature over 30 minutes, NMR spectra recorded, and then 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (181 mg, 0.800 mmol) was added. In-situ NMR spectra 
showed conversion to the dearomatized para, rather than the ortho, intermediate in 93% 
selectivity.  The reaction was stirred for 1 hour at room temperature, and the reaction mixture 
quenched with water. The aqueous phase was extracted with CH2Cl2 (5 x 2 mL), the CH2Cl2 extract 
was dried and concentrated, and the crude oil was purifed by flash silica chromatography. 
Chromatography conditions: 0-80% Hexane/Ethyl acetate, 16 column volumes, 50 g SiO2, flow 
rate 1 column volume per minute. 50.2 mg colorless oil, 65%. 1H-NMR (CDCl3): 9.05 (ß, 1H, (d, 
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J1H-1H=4.2)), 8.24 (γ, 1H, (d, J1H-1H=8.5)), 8.17 (γ, 1H, (d, J1H-1H=8.5)), 7.83 (ε, 1H, (t, J1H-1H=7.2)), 
7.72 (ε, α, 2H, m (overlap)). 13C-NMR: 149.53, 148.94, 134.28 (q, J13C-19F=31.8), 130.41, 130.21, 
128.32, 124.03 (q, J13C-19F=2.2), 123.40 (q, J13C-19F=274.7), 122.95, 117.93 (q, J13C-19F=5.3). 
19F-
NMR: -61.46 (s). HRMS (ESI+): 198.0523  (M+H: 198.0525).  
Fig. S142. In-Situ 19F NMR Spectrum of Ortho and Para Dearomatized Intermediates 
 
Fig. S143. 1H NMR Spectrum: 
 
Fig. S144. 13C NMR Spectrum: 
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Fig. S145. 19F NMR Spectrum: 
 
 
2-Trifluoromethylquinoline: 
Experimental: Quinoline (51.6 mg, 0.400 mmol) was dissolved in 2 mL THF along with BF3 (204 
mg, 0.400 mmol). This was cooled to -30 °C, and combined with K(18-crown-
6)(B3N3Me6CF3)(THF) (2.00 mL, 0.2 M in THF, 0.400 mmol) with stirring. The reaction was 
allowed to warm to room temperature over 30 minutes, and then 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (181 mg, 0.800 mmol) was added. In-situ NMR spectra showed conversion to the 
dearomatized ortho, rather than the para, intermediate in 85% selectivity.   The reaction was stirred 
for 1 hour at room temperature, and the reaction mixture was quenched with water. The aqueous 
phase was extracted with CH2Cl2 (5 x 2 mL), the CH2Cl2 extract dried and concentrated, and the 
crude oil purifed by flash silica chromatography. Chromatography conditions: 0-80% 
Hexane/Ethyl acetate, 16 column volumes, 50 g SiO2, flow rate 1 column volume per minute. 21.6 
mg white solid, 27%.  1H-NMR (CDCl3): 8.36 (α, 1H, (d, J1H-1H=8.5)), 8.24 (α, 1H, (d, J1H-1H=8.5)), 
7.91 (ß, 1H, (d, J1H-1H=8.2)), 7.82 (γ, 1H, (t, J1H-1H=7.6)), 7.75 (ß, 1H, (d, J1H-1H=8.5)), 7.65 (γ, 1H, 
(t, J1H-1H=7.6)). 
13C-NMR: 147.89 (q, J13C-19F=34.6), 147.14, 138.10, 130.79, 130.08, 128.83, 
128.57, 127.66, 121.55 (q, J13C-19F=275), 116.75. 
19F-NMR: -67.13 (s). HRMS (ESI+): 198.0522  
(M+H+: 198.0525).  
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Fig. S146. In-Situ 19F NMR Spectrum of Ortho and Para Dearomatized Intermediates 
 
Fig. S147. 1H NMR Spectrum: 
 
Fig. S148. 13C NMR Spectrum: 
 
 
 
S97 
 
Fig. S149. 19F NMR Spectrum: 
 
 
4-(Cinnamylthio)-2,7-bis(trifluoromethyl)quinoline: 
Experimental: 4-(thio)-7-trifluoromethylquinoline (229 mg, 1.00 mmol) was dissolved in 10 mL 
THF and combined with KOtBu (112 mg, 1.00 mmol). After stirring for 5 minutes, cinnamyl 
bromide was added (197 mg, 1.00 mmol). After five additional minutes, the reaction solvent was 
evaporated, 10 mL water added, and the product extracted with CH2Cl2 (5 x 2 mL). The CH2Cl2 
extract was then dried and concentrated, and the crude oil purifed by flash silica chromatography. 
Chromatography conditions: 5-40% Hexane/Ethyl Acetate, 16 column volumes, 100 g SiO2, flow 
rate 1 column volume per minute. 280 mg white solid, 81%. 1H-NMR (CD3OD): 8.75 (δ, 1H, (d, 
J1H-1H=4.9)), 8.37 (γ, 1H, (d, J1H-1H=8.8)), 8.27 (ß, 1H, s), 7.81 (π, 1H, (d, J1H-1H=8.8)), 7.63 (α, 
1H, (d, J1H-1H=4.9)), 7.38 (ν, 2H, (d, J1H-1H=7.7)), 7.28 (ξ, 2H, (t, J1H-1H=7.3)), 7.21 (ζ, 1H, (t J1H-
1H=7.4)), 6.77 (μ, 1H, (d, J1H-1H=15.7)), 6.40 (τ, 1H, (dt, J1H-1H=15.7, 7.0)), 4.09 (ε, 2H, (d, J1H-
1H=7.0)). 
19F-NMR: -63.11 (2, s), -67.98 (1, s). HRMS (ESI+): 346.0872 (M+H+: 346.0877).  
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Fig. S150. 1H NMR Spectrum: 
 
Fig. S151. 13C NMR Spectrum: 
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Fig. S152. 19F NMR Spectrum: 
 
Fig. S153. 1H-1H gCOSY Spectrum: 
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Fig. S154. 1H-13C gHSQCAD Spectrum: 
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Fig. S155. 1H-13C gHMBCAD Spectrum: 
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4-(Cinnamylthio)-2,7-bis(trifluoromethyl)quinoline: 
Experimental: 4-(Cinnamylthio)-2,7-bis(trifluoromethyl)quinoline (204 mg, 0.600 mmol) was 
dissolved in 0.75 mL THF along with BF3 (74 µL, 0.600 mmol). This was cooled to -30 °C, and 
combined with K(18-crown-6)(B3N3Me6CF3)(THF) (3.00 mL, 0.2 M in THF, 0.600 mmol) with 
stirring. The reaction was allowed to warm to room temperature over 10 minutes, and then 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (181 mg, 0.800 mmol) was added. After 10 minutes, the 
solvent was evaporated and the reaction quenched with 5% NaOH solution in water. The aqueous 
phase was extracted with CH2Cl2 (5 x 2 mL), the CH2Cl2 extract dried and concentrated, and the 
crude oil purifed by flash silica chromatography. Chromatography conditions: 0-20% 
Hexane/DCM, 12 column volumes, 25 g SiO2, flow rate 1 column volume per minute. 91.9 mg 
white solid, 37%.  1H-NMR (CDCl3): 8.50 (ß, 1H, s), 8.29 (γ, 1H, (d, J1H-1H=8.8)), 7.82 (π, 1H, (d, 
J1H-1H=8.8)), 7.65 (α, 1H, s), 7.36 (ν, 2H, (d, J1H-1H=7.5)), 7.32 (ξ, 2H, (t, J1H-1H=7.6)), 7.27 (ζ, 1H, 
(t J1H-1H=7.6)), 6.79 (μ, 1H, (d, J1H-1H=15.7)), 6.28 (τ, 1H, (dt, J1H-1H=15.5, 7.1)), 4.04 (ε, 2H, (d, 
J1H-1H=7.0)). 
13C-NMR: 150.86, 148.22 (q, J13C-19F=34.7), 145.49, 135.77, 135.59, 132.79 (q, J13C-
19F=33.1), 128.63 (m), 128.61 (m), 128.53 (m), 128.46 (m), 126.62, 124.92 (d, J13C-19F=24.9), 
123.85 (d, J13C-19F=22), 123.43 (q, J13C-19F=273), 121.40, 121.23 (q, J13C-19F=276), 113.18 (q, J13C-
19F=35.2), 34.36.
19F-NMR: -63.11 (2, s), -67.98 (1, s). HRMS (ESI+): 414.0742  (M+H+: 
414.0751).  
Fig. S156. 1H NMR Spectrum: 
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Fig. S157. 13C NMR Spectrum: 
 
Fig. S158. 19F NMR Spectrum: 
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Fig. S159. 1H-1H gCOSY Spectrum: 
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Fig. S160. 1H-13C gHSQCAD Spectrum: 
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Fig. S161. 1H-13C gHMBCAD Spectrum: 
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Comparison Between 2 and SiMe3CF3 in Aromatic Trifluoromethylation 
Optimization of Activator and Solvent for 1a 
 
 
 (NMe4)(F) (NBu4)(SiPh3F2) KOAc Cs2CO3 K2CO3 KOtBu none 
Tol 6.6% 38% 0% 0% 0% 0.8% 0% 
THF 19% 53% 0.4% 1.2% 0.4% 1.0% 0% 
DMF 20% 60% 55% 30% 32% 6.8% 0.6% 
DCM 0.3% 3.2% 0% 0% 0% 0.3% 0% 
 
A stock solution of 1,4-dinitrobenzene (1.0 M) containing (0.1 M) hexamethylbenzene as internal 
standard were prepared. This was used to prepare 1 mL (0.1 M) reaction mixtures, which were 
charged with 0.1 mmol of activator and stirred in a 8 mL scintillation vial. SiMe3CF3  (17.72 L, 
0.120 mmol) was added, and the mixture stirred for 1 hour. Yield was determined by GC (FID). 
A reaction with 2 in place of SiMe3CF3/activator in THF afforded 58% chemical yield.   
Control Reactions for 1b 
2 Trifluoromethylation of Quinoline Using 1b 
 
Quinoline (11.82 L, 0.10 mmol) was dissolved in 1.0 mL of THF and BF3•OEt2 (12.34 L, 0.10 
mmol) added in an 20 mL scintillation vial charged with a small magnetic stirbar and chilled to -
30 C. One equiv. SiMe3CF3 was added as a -30 °C solution (0.12 mL, 1.0 M THF) to the reaction 
mixture. Solid (NBu4)(SiPh3F2) (53.5 mg, 0.10 mmol) was added and the vial was shaken and kept 
at -30 C for 5 minutes. The vial was then warmed to 25 C and stirred with 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ) (22.7 mg, 0.10 mmol) for 1 hour. Chemical yield (58%) was 
determined by integration of the product peak against fluorobenzene as internal standard in the 19F 
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NMR spectrum. When (NBu4)(SiPh3F2) was added before SiMe3CF3, 1% chemical yield was 
observed. A reaction with 2 in place of SiMe3CF3 afforded 32% chemical yield. 
2 Trifluoromethylation of 2,4,6 Trichloro Quinalozine Using 1b 
 
2,4,6 trichloroquinazoline (11.5 mg, 0.05 mmol) was dissolved in 1 mL of THF along with (14.78 
L, 0.10 mmol) of SiMe3CF3. (NBu4)(SiPh3F2) (54.1 mg, 0.10 mmol) was added to the reaction 
mixture, which was vigorously shaken until homogeneous. Fluorobenzene internal standard was 
then added and the reaction mixture transferred to an NMR tube for 19F NMR analysis. The product 
was formed in quantitative chemical yield. When SiMe3CF3 was added last, the reaction provided 
84% chemical yield. A reaction with 2 in place of SiMe3CF3 also affords quantitative chemical 
yield. 
2 Trifluoromethylation of 4-Phenyl Benzoyl Chloride Using 1b 
 
4-Phenyl benzoyl chloride (9.1 mg, 0.05 mmol) was dissolved in 1 mL of THF along with 
(NBu4)(SiPh3F2) (53.7 mg, 0.10 mmol) at 25 C in an 8 mL scintillation vial. SiMe3CF3 (14.78 L, 
0.10 mmol) was added. The reaction mixture was shaken until homogeneous, charged with 
fluorobenzene as internal standard and transferred to an NMR tube for 19F NMR analysis. 45% 
chemical yield. Adding (NBu4)(SiPh3F2) last provided 40% chemical yield. Using reagent 2, the 
isolated yield was 84% (see above). 
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Kinetic Measurements of CF3 Transfer and Decomposition: 
General Protocol: 
2 (dispensed as a -78 °C 0.2 M stock solution in THF) was added to a solution of electrophile at -
78 °C in a glovebox cold well to give desired concentrations of 2 and electrophile. A 0.7 mL 
sample of this reaction mixture was then transferred into a -78 °C NMR tube, and the tube rapidly 
(<30 s) transferred to a -78 °C dry ice acetone bath outside the glovebox. The NMR samples were 
then inserted into an NMR spectrometer probe held at the desired reaction temperature, and the 
reaction progress monitored by 19F NMR spectroscopy (spectra were taken at the rate of 1 spectrum 
per minute to provide kinetic traces. d1 = 2.5 s, pw = 2.958 µs, aq = 602.931 ms; interpulse delay: 
3.1 s). For determination of reactant order, initial rates were measured through a linear fit of the 
first 30 minutes of the reaction, or of data encompassing the first 15% of reaction progress, 
whichever was shorter. In all other cases, reaction profiles were obtained through at least 75% 
reaction progress. Concentrations were calculated by integration against a known concentration of 
fluorobenzene internal standard.  
Example Linear Fit 
 
0.025 M 2 with 0.025 M 7 at -10 C in THF. Rate: -0.00283 mM/s for consumption of 2; R2 = 
0.999. 
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Order in 2 for CF3- transfer to 7-8 
 
2 (M) 0.16 M 0.08 M 0.04 M 0.02 M 0.01 M 
7 (rate) 1.8(3)*10-2 1.0(1)*10-2 5.2(7)*10-3 3.0(3)*10-3 1.5(2)*10-3 
8 (rate) 1.9(3)*10-2 1.0(2)*10-2 5.8(1)*10-3 3.5(6)*10-3 1.8(1)*10-3 
Reaction rates with uncertainty in mM/s for 0.04 M of electrophile with varying equivalents of 2 
 
0.025 M 2 (0.00625 M, 0.0125 M, 0.025 M, 0.05 M, 1 M) 7, slope 0.06 following 2 decomposition 
 
S111 
 
 
0.025 M 2 (0.00625 M, 0.0125 M, 0.025 M, 0.05 M, 1 M) 8 slope 0.09 following 8 consumption 
Order in 7-8 for CF3- transfer from 2 
 
E (M) 0.1 M 0.05 M 0.025 M 0.0125 M 0.00625 M 
7 (rate) 4(1)*10-3 3.1(5)*10-3 3.1(4)*10-3 2.9(4)*10-3 3.2(5)*10-3 
8 (rate) 4.0(3)*10-3 4.01(7)*10-3 3.8(1)*10-3 3.6(4)*10-3 3.10(3)*10-3 
 
Reaction rates with uncertainty in mM/s for 0.025 M of 2 with varying equivalents of electrophile 
(electrophile=E) 
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0.04 M 7 (0.01 M, 0.02 M, 0.04M, 0.08 M, 0.16 M) 2, slope 0.89 following 2 decomposition 
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0.04 M 8 (0.01 M, 0.02 M, 0.04M, 0.08 M, 0.16 M) 2 slope 0.83 following 8 consumption 
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Eyring Plot for 7 
 
Table of k Values (s-1) for Eyring Analysis 
Temperature -40 °C -10 C 0 C 10 C 
k (s-1) 8.3*10-7 1.5(3)*10-4 8(2)*10-4 4.2(7)*10-3 
 
Linear fit parameters:  
Slope: -11700(479); Intercept: 30(1) 
Enthalpy of activation: 23.3(9) kCal/mol; Entropy of activation: 12(3) eu.  
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Kinetic Traces for Thermal Decomposition of 2, 2a, and 2b at 60 C 
 
2a was prepared in-situ by addition of one equiv. 18-crown-6 to solutions of 2. 
  
S116 
 
Kinetic Traces for Thermal Decomposition of 2, 2a, and 2b at 60 C 
 
2: k=1.25 M-1s-1, linear fit R2=0.986. 
2a: k=0.364 M-1s-1, linear fit R2=0.983. 
2b: k=0.0280 M-1s-1, linear fit R2=0.996. 
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CF3- transfer to 7 from 2, 2b, and 2b activated with K+ at 10 C 
 
0.1 M 2 and 0.1 M 7, 10 C. One equiv. KB(C6F5)4  (K+) was added last as a THF solution at -78 
C to activate 2b prior to kinetic measurements at 10 °C in 2b & 1K+ and 5 equiv. added in 2b & 
5K+. 
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